_id
6915ee51bc934aba376b1e98
Ticker
RGBPP
Name
Regen BioPharma Inc
Exchange
PINK
Address
4700 Spring Street, La Mesa, CA, United States, 91942
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://regenbiopharmainc.com
Description
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is also developing HemaXellarate, a cellular therapeutic product of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax which is treated with siRNA to inhibit NR2F6 and the cells re-infused to the patient; DiffronC, uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuroCAR comprising of CAR-T cells which is treated with an shRNA targeting the gene NR2F6. Regen BioPharma was incorporated in 2012 and is based in La Mesa, California.
Last Close
0.0361
Volume
34
Current Price
0.0322
Change
-0.0001
Last Updated
2026-01-06T10:12:48.525Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
1347558
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
-50635
Cost Of Revenue
90000
Gross Profit
-140635
Operating Expenses
151488
Operating Income
-123057
Interest Expense
-268522
Pretax Income
-572473
Net Income
-572472
Eps
-0.024337757424229348
Dividends Per Share
-
Shares Outstanding
158726000
Income Tax Expense
-
EBITDA
253255
Operating Margin
243.02755011355782
Total Other Income Expense Net
-449416
Cash
716
Short Term Investments
-
Receivables
94873
Inventories
-
Total Current Assets
143351
Property Plant Equipment
-
Total Assets
161084
Payables
29669
Short Term Debt
793699
Long Term Debt
-
Total Liabilities
5378456
Equity
-5217373
Bs_currency_symbol
-
Depreciation
39509
Change In Working Capital
-356819
Cash From Operations
-160005
Capital Expenditures
3
Cash From Investing
-
Cash From Financing
227799
Net Change In Cash
67794
Cf_currency_symbol
-
PE
-
PB
-0.14517026748902176
ROE
10.972418494901554
ROA
-355.387251371955
FCF
-160008
Fcf Percent
3.1600276488594847
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
8.3
Garp Investing Score
3
Growth Investing Score
2.5
Momentum Investing Score
3.5
Net Net Investing Score
2
Quality Investing Score
4.5
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
-50635
Quarters > 0 > income Statement > cost Of Revenue
90000
Quarters > 0 > income Statement > gross Profit
-140635
Quarters > 0 > income Statement > operating Expenses
151488
Quarters > 0 > income Statement > operating Income
-123057
Quarters > 0 > income Statement > interest Expense
-268522
Quarters > 0 > income Statement > pretax Income
-572473
Quarters > 0 > income Statement > net Income
-572472
Quarters > 0 > income Statement > eps
-0.024337757424229348
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
23521970
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
253255
Quarters > 0 > income Statement > operating Margin
243.02755011355782
Quarters > 0 > income Statement > total Other Income Expense Net
-449416
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
716
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
94873
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
143351
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
161084
Quarters > 0 > balance Sheet > payables
29669
Quarters > 0 > balance Sheet > short Term Debt
793699
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5378456
Quarters > 0 > balance Sheet > equity
-5217373
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-572469
Quarters > 0 > cash Flow > depreciation
39509
Quarters > 0 > cash Flow > change In Working Capital
-356819
Quarters > 0 > cash Flow > cash From Operations
-160005
Quarters > 0 > cash Flow > capital Expenditures
3
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
227799
Quarters > 0 > cash Flow > net Change In Cash
67794
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.024337757424229348
Quarters > 0 > ratios > PB
-0.14517026748902176
Quarters > 0 > ratios > ROE
10.972418494901554
Quarters > 0 > ratios > ROA
-355.387251371955
Quarters > 0 > ratios > FCF
-160008
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
3.1600276488594847
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
59065
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
59065
Quarters > 1 > income Statement > operating Expenses
99821
Quarters > 1 > income Statement > operating Income
-40756
Quarters > 1 > income Statement > interest Expense
37277
Quarters > 1 > income Statement > pretax Income
-167292
Quarters > 1 > income Statement > net Income
-167292
Quarters > 1 > income Statement > eps
-0.007043130522733054
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
23752506
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-130015
Quarters > 1 > income Statement > operating Margin
-69.00194700753407
Quarters > 1 > income Statement > total Other Income Expense Net
-126536
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1761
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
177147
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
179108
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
196841
Quarters > 1 > balance Sheet > payables
30477
Quarters > 1 > balance Sheet > short Term Debt
1036244
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
6012532
Quarters > 1 > balance Sheet > equity
-5815691
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-167294
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
20170
Quarters > 1 > cash Flow > cash From Operations
-55977
Quarters > 1 > cash Flow > capital Expenditures
3
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
55976
Quarters > 1 > cash Flow > net Change In Cash
0
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.007043130522733054
Quarters > 1 > ratios > PB
-0.13151157673267028
Quarters > 1 > ratios > ROE
2.876562733473976
Quarters > 1 > ratios > ROA
-84.98839164604935
Quarters > 1 > ratios > FCF
-55980
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.9477694065859646
Quarters > 1 > health Score
18
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
59065
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
59065
Quarters > 2 > income Statement > operating Expenses
172414
Quarters > 2 > income Statement > operating Income
-113349
Quarters > 2 > income Statement > interest Expense
34968
Quarters > 2 > income Statement > pretax Income
-19354
Quarters > 2 > income Statement > net Income
-19354
Quarters > 2 > income Statement > eps
-0.0047086988308539714
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
4110265
Quarters > 2 > income Statement > income Tax Expense
100651
Quarters > 2 > income Statement > EBITDA
15614
Quarters > 2 > income Statement > operating Margin
-191.90552780834673
Quarters > 2 > income Statement > total Other Income Expense Net
93995
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1761
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
149723
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
151749
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
169482
Quarters > 2 > balance Sheet > payables
33703
Quarters > 2 > balance Sheet > short Term Debt
967632
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
5867881
Quarters > 2 > balance Sheet > equity
-5698399
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-19355
Quarters > 2 > cash Flow > depreciation
12639
Quarters > 2 > cash Flow > change In Working Capital
-94514
Quarters > 2 > cash Flow > cash From Operations
-101230
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
102856
Quarters > 2 > cash Flow > net Change In Cash
1626
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.0047086988308539714
Quarters > 2 > ratios > PB
-0.023225915384303557
Quarters > 2 > ratios > ROE
0.3396392565701349
Quarters > 2 > ratios > ROA
-11.419501775999812
Quarters > 2 > ratios > FCF
-101230
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-1.7138745449928046
Quarters > 2 > health Score
15
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
59065
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
120443
Quarters > 3 > income Statement > operating Income
-61378
Quarters > 3 > income Statement > interest Expense
37991
Quarters > 3 > income Statement > pretax Income
-515385
Quarters > 3 > income Statement > net Income
-515384
Quarters > 3 > income Statement > eps
-0.02391051159876749
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
21554704
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-103.91602471853044
Quarters > 3 > income Statement > total Other Income Expense Net
-416016
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
135
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
122298
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
173683
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
191416
Quarters > 3 > balance Sheet > payables
36005
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
5870460
Quarters > 3 > balance Sheet > equity
-5679044
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-515384
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
431163
Quarters > 3 > cash Flow > cash From Operations
-66379
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
65799
Quarters > 3 > cash Flow > net Change In Cash
-581
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.02391051159876749
Quarters > 3 > ratios > PB
-0.12221449046705748
Quarters > 3 > ratios > ROE
9.075189415683344
Quarters > 3 > ratios > ROA
-269.24812972792245
Quarters > 3 > ratios > FCF
-66379
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.1238296791670195
Quarters > 3 > health Score
22
Annuals > 0 > quarter
2025-09-30
Annuals > 0 > income Statement > revenue
126560
Annuals > 0 > income Statement > cost Of Revenue
90000
Annuals > 0 > income Statement > gross Profit
36560
Annuals > 0 > income Statement > operating Expenses
485101
Annuals > 0 > income Statement > operating Income
-338540
Annuals > 0 > income Statement > interest Expense
-158286
Annuals > 0 > income Statement > pretax Income
-1274502
Annuals > 0 > income Statement > net Income
-1274502
Annuals > 0 > income Statement > eps
-0.05418347187756808
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
23521970
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-338540
Annuals > 0 > income Statement > operating Margin
-267.49367888748424
Annuals > 0 > income Statement > total Other Income Expense Net
-935962
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
716
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
94873
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
143351
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
161084
Annuals > 0 > balance Sheet > payables
29669
Annuals > 0 > balance Sheet > short Term Debt
793699
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5378456
Annuals > 0 > balance Sheet > equity
-5217373
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-1274502
Annuals > 0 > cash Flow > depreciation
52148
Annuals > 0 > cash Flow > change In Working Capital
-254384
Annuals > 0 > cash Flow > cash From Operations
-383591
Annuals > 0 > cash Flow > capital Expenditures
4
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
452430
Annuals > 0 > cash Flow > net Change In Cash
68839
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.05418347187756808
Annuals > 0 > ratios > PB
-0.16230216241008644
Annuals > 0 > ratios > ROE
24.42804070170946
Annuals > 0 > ratios > ROA
-791.2033473218942
Annuals > 0 > ratios > FCF
-383595
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-3.03093394437421
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2024-09-30
Annuals > 1 > income Statement > revenue
236560
Annuals > 1 > income Statement > cost Of Revenue
77215
Annuals > 1 > income Statement > gross Profit
159345
Annuals > 1 > income Statement > operating Expenses
577534
Annuals > 1 > income Statement > operating Income
-418189
Annuals > 1 > income Statement > interest Expense
72445
Annuals > 1 > income Statement > pretax Income
-867252
Annuals > 1 > income Statement > net Income
-867252
Annuals > 1 > income Statement > eps
-0.20582156255050596
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
4213611
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-418189
Annuals > 1 > income Statement > operating Margin
-176.77925262089954
Annuals > 1 > income Statement > total Other Income Expense Net
-449063
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
716
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
143351
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
161084
Annuals > 1 > balance Sheet > payables
29668
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
5378456
Annuals > 1 > balance Sheet > equity
-5217372
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-867252
Annuals > 1 > cash Flow > depreciation
28998
Annuals > 1 > cash Flow > change In Working Capital
-254384
Annuals > 1 > cash Flow > cash From Operations
-693141
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
572819
Annuals > 1 > cash Flow > net Change In Cash
-120322
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.20582156255050596
Annuals > 1 > ratios > PB
-0.02907402347388685
Annuals > 1 > ratios > ROE
16.62239150284856
Annuals > 1 > ratios > ROA
-538.3849420178292
Annuals > 1 > ratios > FCF
-693141
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.9300853905985798
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2023-09-30
Annuals > 2 > income Statement > revenue
236560
Annuals > 2 > income Statement > cost Of Revenue
60000
Annuals > 2 > income Statement > gross Profit
236560
Annuals > 2 > income Statement > operating Expenses
923510
Annuals > 2 > income Statement > operating Income
-686950
Annuals > 2 > income Statement > interest Expense
59448
Annuals > 2 > income Statement > pretax Income
1156508
Annuals > 2 > income Statement > net Income
1023508
Annuals > 2 > income Statement > eps
0.2893748111020669
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3536963
Annuals > 2 > income Statement > income Tax Expense
442447
Annuals > 2 > income Statement > EBITDA
3118862
Annuals > 2 > income Statement > operating Margin
-290.3914440311126
Annuals > 2 > income Statement > total Other Income Expense Net
1843458
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
121037
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
0
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
131037
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
353617
Annuals > 2 > balance Sheet > payables
29674
Annuals > 2 > balance Sheet > short Term Debt
606590
Annuals > 2 > balance Sheet > long Term Debt
149614
Annuals > 2 > balance Sheet > total Liabilities
5457616
Annuals > 2 > balance Sheet > equity
-5104000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
1156507
Annuals > 2 > cash Flow > depreciation
864
Annuals > 2 > cash Flow > change In Working Capital
-1928511
Annuals > 2 > cash Flow > cash From Operations
-173917
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
243750
Annuals > 2 > cash Flow > net Change In Cash
69833
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.2893748111020669
Annuals > 2 > ratios > PB
-0.024947231191222566
Annuals > 2 > ratios > ROE
-20.05305642633229
Annuals > 2 > ratios > ROA
289.43970453909174
Annuals > 2 > ratios > FCF
-173917
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.7351919174839364
Annuals > 2 > health Score
39
Annuals > 3 > quarter
2022-09-30
Annuals > 3 > income Statement > revenue
235517
Annuals > 3 > income Statement > cost Of Revenue
50000
Annuals > 3 > income Statement > gross Profit
185517
Annuals > 3 > income Statement > operating Expenses
575122
Annuals > 3 > income Statement > operating Income
-339605
Annuals > 3 > income Statement > interest Expense
255287
Annuals > 3 > income Statement > pretax Income
2443532
Annuals > 3 > income Statement > net Income
5436455
Annuals > 3 > income Statement > eps
0.14563818530077555
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
37328500
Annuals > 3 > income Statement > income Tax Expense
-2992923
Annuals > 3 > income Statement > EBITDA
2992924
Annuals > 3 > income Statement > operating Margin
-144.19553577873359
Annuals > 3 > income Statement > total Other Income Expense Net
2783137
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
51204
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
254273
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
336422
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
559002
Annuals > 3 > balance Sheet > payables
28799
Annuals > 3 > balance Sheet > short Term Debt
1274050
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
8595061
Annuals > 3 > balance Sheet > equity
-8036059
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
2443531
Annuals > 3 > cash Flow > depreciation
71067
Annuals > 3 > cash Flow > change In Working Capital
-3137415
Annuals > 3 > cash Flow > cash From Operations
-606921
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
25000
Annuals > 3 > cash Flow > cash From Financing
-94036
Annuals > 3 > cash Flow > net Change In Cash
-675958
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.14563818530077555
Annuals > 3 > ratios > PB
-0.16722450644028372
Annuals > 3 > ratios > ROE
-67.6507601549466
Annuals > 3 > ratios > ROA
972.5287208274747
Annuals > 3 > ratios > FCF
-606921
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-2.576973212124815
Annuals > 3 > health Score
39
Valuation > metrics > PE
-0.024337757424229348
Valuation > metrics > PB
-0.14517026748902176
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
10.972418494901554
Profitability > metrics > ROA
-399.34984757692655
Profitability > metrics > Net Margin
11.30585563345512
Profitability > final Score
52
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-0.45827529960301205
Risk > final Score
28
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.1741031956549198
Liquidity > metrics > Quick Ratio
0.1741031956549198
Liquidity > final Score
19
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
6
Prev Profitabilities > 1
1
Prev Profitabilities > 2
18
Prev Risks > 0
26
Prev Risks > 1
17
Prev Risks > 2
24
Prev Liquidities > 0
18
Prev Liquidities > 1
18
Prev Liquidities > 2
100
Updated At
2026-01-20T22:28:58.816Z
Earnings History > 0 > period
2021-06-30
Earnings History > 0 > report Date
2021-09-30
Earnings History > 0 > date
2021-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.0003
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.0003
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0021
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0021
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0.0002
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.0002
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0.0008
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0.0008
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.0011
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0.0011
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.0016
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0.0016
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0026
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0026
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.0029
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.0029
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-09-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.0003
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0.0003
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-30
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0513
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0513
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0011
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0011
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.0012
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.0012
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.006
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.006
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0007
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0007
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0078
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0078
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-12-31
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0195
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0195
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-06-30
Earnings History > 16 > report Date
2017-09-30
Earnings History > 16 > date
2017-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0097
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0097
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-06-30
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.019
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.019
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-03-31
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0093
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0093
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-09-30
Earnings History > 19 > report Date
2016-12-31
Earnings History > 19 > date
2016-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0039
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0039
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-06-30
Earnings History > 20 > report Date
2016-09-30
Earnings History > 20 > date
2016-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0072
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0072
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2016-03-31
Earnings History > 21 > report Date
2016-06-30
Earnings History > 21 > date
2016-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0078
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0078
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2015-12-31
Earnings History > 22 > report Date
2016-03-31
Earnings History > 22 > date
2015-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0058
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0058
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-09-30
Earnings History > 23 > report Date
2015-12-31
Earnings History > 23 > date
2015-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.0059
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.0059
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2015-06-30
Earnings History > 24 > report Date
2015-09-30
Earnings History > 24 > date
2015-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.0046
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.0046
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2015-03-31
Earnings History > 25 > report Date
2015-06-30
Earnings History > 25 > date
2015-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.0075
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.0075
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2014-12-31
Earnings History > 26 > report Date
2015-03-31
Earnings History > 26 > date
2014-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.0088
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.0088
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2014-09-30
Earnings History > 27 > report Date
2014-12-31
Earnings History > 27 > date
2014-09-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.0042
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.0042
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2014-06-30
Earnings History > 28 > report Date
2014-09-30
Earnings History > 28 > date
2014-06-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.002
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.002
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2014-03-31
Earnings History > 29 > report Date
2014-06-30
Earnings History > 29 > date
2014-03-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.0032
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.0032
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2013-12-31
Earnings History > 30 > report Date
2014-03-31
Earnings History > 30 > date
2013-12-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.0036
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-0.0036
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2013-09-30
Earnings History > 31 > report Date
2013-12-31
Earnings History > 31 > date
2013-09-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.004
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.004
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2013-06-30
Earnings History > 32 > report Date
2013-09-30
Earnings History > 32 > date
2013-06-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.0023
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-0.0023
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2013-03-31
Earnings History > 33 > report Date
2013-06-30
Earnings History > 33 > date
2013-03-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.0031
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.0031
Earnings History > 33 > surprise Percent
-
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is also developing HemaXellarate, a cellular therapeutic product of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax which is treated with siRNA to inhibit NR2F6 and the cells re-infused to the patient; DiffronC, uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuroCAR comprising of CAR-T cells which is treated with an shRNA targeting the gene NR2F6. Regen BioPharma was incorporated in 2012 and is based in La Mesa, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Regen BioPharma Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2021-06-30
EPS Actual
-0.0003
EPS Estimate
0
EPS Difference
-0.0003
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.